MedTrace Logo

Cardiac Output Changes During Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Cesarean Section

NCT02737813 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2017-07-31

No results posted yet for this study

Summary

Spinal block leads to the reduction of systemic vascular resistance (SVR) which may effect the cardiac output. Ngan Kee et al. has showed that spina block with 0.5% hyperbaric bupivacaine for Cesarean section combined with intravenous infusion norepinephrine had higher cardiac output than those who received phenylephrine

Conditions

Interventions

DRUG

Isobaric marcaine

Isobaric marcaine 2.2 mL for spinal block

DRUG

Hyperbaric marcaine

Hyperbaric marcaine 2.2 mL for spinal block

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Sirilak Suksompong, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-29
Primary Completion
2016-11-11
Completion
2016-11-15

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02737813 on ClinicalTrials.gov